RU99115892A - PHOSPHODYESTERASE 8A - Google Patents
PHOSPHODYESTERASE 8AInfo
- Publication number
- RU99115892A RU99115892A RU99115892/13A RU99115892A RU99115892A RU 99115892 A RU99115892 A RU 99115892A RU 99115892/13 A RU99115892/13 A RU 99115892/13A RU 99115892 A RU99115892 A RU 99115892A RU 99115892 A RU99115892 A RU 99115892A
- Authority
- RU
- Russia
- Prior art keywords
- polypeptide
- polynucleotide
- pde8a
- compound
- seq
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 claims 22
- 229920000023 polynucleotide Polymers 0.000 claims 21
- 239000002157 polynucleotide Substances 0.000 claims 21
- 102100005346 PDE8A Human genes 0.000 claims 17
- 101700080696 PDE8A Proteins 0.000 claims 17
- 150000001875 compounds Chemical class 0.000 claims 16
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 8
- 102000004965 antibodies Human genes 0.000 claims 5
- 108090001123 antibodies Proteins 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 210000004027 cells Anatomy 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 230000002708 enhancing Effects 0.000 claims 2
- 230000000051 modifying Effects 0.000 claims 2
- 229920002676 Complementary DNA Polymers 0.000 claims 1
- 210000004408 Hybridomas Anatomy 0.000 claims 1
- 230000000692 anti-sense Effects 0.000 claims 1
- 230000000295 complement Effects 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000001963 growth media Substances 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
Claims (32)
a) полинуклеотида по п. 5;
b) ДНК, которая гибридизуется в умеренно строгих условиях с полинуклеотидом (а).9. Polynucleotide encoding a human PDE8 polypeptide selected from the group consisting of:
a) the polynucleotide according to claim 5;
b) DNA that hybridizes under moderately stringent conditions to polynucleotide (a).
a) полинуклеотида по любому из пп. 6 - 8;
b) ДНК, которая гибридизуется в умеренно строгих условиях с полинуклеотидом (а).10. Polynucleotide encoding a human PDE8 polypeptide selected from the group consisting of:
a) polynucleotide according to any one of paragraphs. 6 to 8;
b) DNA that hybridizes under moderately stringent conditions to polynucleotide (a).
a) выращивания клетки-хозяина по п. 17 в условиях, пригодных для экспрессии полипептида PDE8;
b) выделения полипептида PDE8 из клетки-хозяина или среды ее выращивания.18. A method of obtaining a PDE8 polypeptide, comprising the steps of:
a) growing a host cell according to claim 17 under conditions suitable for expression of a PDE8 polypeptide;
b) isolating the PDE8 polypeptide from the host cell or its growth medium.
a) контактирования полипептида PDE8A с соединением в условиях, которые позволяют связывание между этим соединением и полипептидом PDE8A;
b) обнаружение связывания этого соединения с полипептидом PDE8A;
c) идентификации этого соединения как партнера специфического связывания полипептида PDE8A.23. A method for identifying a PDE8A polypeptide specific binding partner compound, comprising the steps of:
a) contacting a PDE8A polypeptide with a compound under conditions that allow binding between this compound and a PDE8A polypeptide;
b) detecting binding of this compound to the PDE8A polypeptide;
c) identifying this compound as a specific binding partner of a PDE8A polypeptide.
a) контактирования полинуклеотида PDE8A с соединением в условиях, которые позволяют связывание между этим соединением и полинуклеотидом PDE8A;
b) обнаружение связывания этого соединения с полинуклеотидом PDE8A;
c) идентификации этого соединения как партнера специфического связывания полинуклеотида PDE8A.27. A method for identifying a partner compound for specific binding of a PDE8A polynucleotide, comprising the steps of:
a) contacting a PDE8A polynucleotide with a compound under conditions that allow binding between this compound and a PDE8A polynucleotide;
b) detecting the binding of this compound to the PDE8A polynucleotide;
c) identifying this compound as a specific binding partner of a PDE8A polynucleotide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/951,648 | 1997-10-16 | ||
US08/951,648 US5932465A (en) | 1997-10-16 | 1997-10-16 | Phosphodiesterase 8A |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99115892A true RU99115892A (en) | 2002-03-27 |
RU2272841C2 RU2272841C2 (en) | 2006-03-27 |
Family
ID=25491965
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99115892/13A RU2272841C2 (en) | 1997-10-16 | 1998-10-16 | Polypeptide with phosphodiesterase enzymatic activity |
RU2005136013/13A RU2005136013A (en) | 1997-10-16 | 2005-11-21 | PHOSPHODYESTERASE 8A |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005136013/13A RU2005136013A (en) | 1997-10-16 | 2005-11-21 | PHOSPHODYESTERASE 8A |
Country Status (14)
Country | Link |
---|---|
US (4) | US5932465A (en) |
EP (2) | EP1571216A3 (en) |
JP (1) | JP2001512327A (en) |
CN (2) | CN1229499C (en) |
AT (1) | ATE295423T1 (en) |
AU (1) | AU1097499A (en) |
BR (1) | BR9806318A (en) |
CA (1) | CA2275135A1 (en) |
DE (1) | DE69830143T2 (en) |
ES (1) | ES2245485T3 (en) |
IL (3) | IL130287A0 (en) |
NO (1) | NO992916L (en) |
RU (2) | RU2272841C2 (en) |
WO (1) | WO1999019495A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2238283C (en) | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
EP0967284A1 (en) * | 1998-05-28 | 1999-12-29 | Pfizer Limited | Phosphodiesterases |
US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
GB9922125D0 (en) | 1999-09-17 | 1999-11-17 | Pfizer Ltd | Phosphodiesterase enzymes |
US6673564B2 (en) * | 1999-10-18 | 2004-01-06 | Millennium Pharmaceuticals, Inc. | Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
CN1297049A (en) * | 1999-11-23 | 2001-05-30 | 上海博容基因开发有限公司 | Polypeptide-human cyclophosphate guanine suppressed phosphodiesterase 17 and polynucleotide for coding said polypeptide |
US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
CN1312381A (en) * | 2000-03-07 | 2001-09-12 | 上海博德基因开发有限公司 | Human cyclic AMP phosphodiesterase 13 as one new polypeptide and polynucleotides encoding this polypeptide |
US7138259B2 (en) * | 2000-09-12 | 2006-11-21 | University Of Washington | PDEs and uses thereof |
IL159722A0 (en) * | 2001-07-10 | 2004-06-20 | Oligos Etc Inc | Pharmaceutical compositions containing oligonucleotides |
WO2004042388A2 (en) * | 2002-11-08 | 2004-05-21 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) |
WO2005089505A2 (en) * | 2004-03-19 | 2005-09-29 | Yale University | Detection, isolation and uses of renalase (monoamine oxidase c) |
JP2009512711A (en) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Regulation of neurogenesis by PDE inhibition |
US7858084B2 (en) | 2005-11-21 | 2010-12-28 | Yale University | Methods of treatment with renalase (monoamine oxidase C) |
US20080260643A1 (en) * | 2007-03-27 | 2008-10-23 | Omeros Corporation | Use of pde7 inhibitors for the treatment of movement disorders |
EP2430191B1 (en) * | 2009-05-12 | 2018-09-19 | Koninklijke Philips N.V. | Phosphodiesterase 4d7 as prostate cancer marker |
AU2011362576B2 (en) * | 2011-03-11 | 2017-06-08 | Alexion Pharmaceuticals, Inc. | NPP1 fusion proteins |
RU2760943C2 (en) * | 2011-09-15 | 2021-12-01 | Алексион Фармасьютикалз, Инк. | Npp1 fusion proteins |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0176693B1 (en) * | 1989-12-22 | 1999-04-01 | 레지널드 디. 쇼트보그; 제롬 반 쥘렌 | Endogenous gene expression modification with regulatory element |
WO1992020808A1 (en) * | 1991-05-15 | 1992-11-26 | Cell Genesys, Inc. | Genomic modifications with homologous dna targeting |
TW402639B (en) * | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
US5798246A (en) * | 1996-03-25 | 1998-08-25 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterase |
-
1997
- 1997-10-16 US US08/951,648 patent/US5932465A/en not_active Expired - Fee Related
-
1998
- 1998-10-16 RU RU99115892/13A patent/RU2272841C2/en not_active IP Right Cessation
- 1998-10-16 BR BR9806318-9A patent/BR9806318A/en not_active Application Discontinuation
- 1998-10-16 CA CA002275135A patent/CA2275135A1/en not_active Abandoned
- 1998-10-16 CN CNB988025817A patent/CN1229499C/en not_active Expired - Fee Related
- 1998-10-16 AU AU10974/99A patent/AU1097499A/en not_active Abandoned
- 1998-10-16 EP EP05009465A patent/EP1571216A3/en not_active Withdrawn
- 1998-10-16 WO PCT/US1998/021956 patent/WO1999019495A1/en not_active Application Discontinuation
- 1998-10-16 DE DE69830143T patent/DE69830143T2/en not_active Revoked
- 1998-10-16 CN CNA2005101137657A patent/CN1800399A/en active Pending
- 1998-10-16 AT AT98953651T patent/ATE295423T1/en not_active IP Right Cessation
- 1998-10-16 EP EP98953651A patent/EP0944725B1/en not_active Revoked
- 1998-10-16 US US09/174,437 patent/US6133007A/en not_active Expired - Fee Related
- 1998-10-16 JP JP52275099A patent/JP2001512327A/en not_active Withdrawn
- 1998-10-16 IL IL13028798A patent/IL130287A0/en not_active IP Right Cessation
- 1998-10-16 ES ES98953651T patent/ES2245485T3/en not_active Expired - Lifetime
-
1999
- 1999-06-03 IL IL130287A patent/IL130287A/en unknown
- 1999-06-15 NO NO992916A patent/NO992916L/en not_active Application Discontinuation
-
2000
- 2000-10-11 US US09/686,055 patent/US6566087B1/en not_active Expired - Fee Related
-
2003
- 2003-05-19 US US10/440,998 patent/US20030215919A1/en not_active Abandoned
-
2005
- 2005-11-21 RU RU2005136013/13A patent/RU2005136013A/en unknown
-
2006
- 2006-05-17 IL IL175698A patent/IL175698A0/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99115892A (en) | PHOSPHODYESTERASE 8A | |
RU2005136013A (en) | PHOSPHODYESTERASE 8A | |
EP0529742B1 (en) | Alpha-amidating enzyme compositions and processes for their production and use | |
HK1222415A1 (en) | Circovirus sequence associated with porcine wasting disease (pwd) (pwd) | |
CA2143491A1 (en) | A novel peptide related to human programmed cell death and dna encoding it | |
CA2363537A1 (en) | Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods | |
CA2222279A1 (en) | Hypoxia inducible factor-1 and method of use | |
RU2004115112A (en) | HUMAN ANTIBODIES WITH MN BINDING ACTIVITY AND CELLULAR ADHESION NEUTRALIZATION | |
JP2004138610A5 (en) | ||
JP2002508923A5 (en) | ||
RU2000103217A (en) | GENES AND POLYPEPTIDES INHIBITING TUMOR DEVELOPMENT AND RELATED TO APOPTOSIS, AND WAYS OF THEIR APPLICATION | |
PT92844A (en) | METHOD FOR PRODUCING AND USING HYDROLASE OF ACIL-PEPTIDEES | |
JP2003501010A5 (en) | ||
JP2003530821A5 (en) | ||
KR970705923A (en) | Cytokine Designated LERK-6, designated LERK-6, | |
JP2002523094A5 (en) | ||
CA2241786A1 (en) | Novel amp activated protein kinase | |
CA2427684A1 (en) | Nod2 nucleic acids and proteins | |
RU97106012A (en) | NEW RCA BINDING PROTEINS AND THEIR USE | |
CA2332733A1 (en) | Signal peptides, nucleic acid molecules and methods for treatment of caries | |
FI110433B (en) | Alpha-amidating enzyme - obtd. from rat medullary thyroid carcinoma and used for prodn. of peptidyl amide cpds. having an amino gp. in place of a C-terminal glycine | |
WO2001000798A2 (en) | Cloning and expressing of human cathepsin k in mammalian cells | |
RU97106018A (en) | NEW RCA BINDING PROTEINS AND THEIR USE | |
RU2001123234A (en) | SERINE MAMMAL RACEMASIS | |
EP1092773A3 (en) | Polypeptide and uses thereof |